Health Global Access Project: Analysis & Comment on Johnson & Johnson COVID-19 Vaccine Candidate Pricing and Manufacturing Capacity
April 04, 2020
April 04, 2020
BROOKLYN, New York, April 4 -- Health Global Access Project issued the following news release:
Johnson & Johnson has announced that it intends to sell its COVID-19 vaccine candidate for 10 euros a dose, depending on production costs and volume. This would be a concessionary, no-profit price. Johnson & Johnson further reported that it might be able to produce 5-10 million doses by early 2021 and ramp up to 100-300 million doses by the end of that year, eventually reaching 1 b . . .
Johnson & Johnson has announced that it intends to sell its COVID-19 vaccine candidate for 10 euros a dose, depending on production costs and volume. This would be a concessionary, no-profit price. Johnson & Johnson further reported that it might be able to produce 5-10 million doses by early 2021 and ramp up to 100-300 million doses by the end of that year, eventually reaching 1 b . . .